News

$32 million for the next generation of clinician researchers to pursue critical health and medical research

20 May 2020 The Australian Government will invest almost $32 million through the Medical Research Future Fund (MRFF) in world-leading health and medical research projects. 30 early- to mid-career researchers will be offered 5-year grants funded through the…

FDA allows Veyonda® Pre-IND Submission for COVID-19

19 May 2020 Noxopharm (ASX:NOX) today announces that on advice from the U.S. Food and Drug Administration (FDA), the Company has lodged a pre-Investigational New Drug (pre-IND) submission for a clinical trial of Veyonda® in patients with SARS-CoV-2…

Supporting Victorian Universities

19 May 2020 The Victorian Government will make an unprecedented investment in local universities to protect jobs and support the state’s economic rebound from the coronavirus crisis. Minister for Training and Skills and Higher Education Gayle Tierney joined…

Four new projects announced for National Drug Discovery Centre

19 May 2020 Four research projects have been awarded generous Australian Government subsidies to fast-track their discoveries into new medicines using the National Drug Discovery Centre (NDDC) at The Walter and Eliza Hall Institute.  The centre provides researchers…

Immunological scarring: new research reveals why your immune system can shut down

19 May 2020 Researchers have identified a molecular “switch” that triggers a powerful chain of events in response to severe bacterial or viral infections that could change how we manage patients in intensive care, including those with COVID-19.…

New Angel Groups Provide Lifeline To Early-Stage Startups

19 May 2020 More than $10 million in private sector capital is set to be unlocked to help over 40 early-stage Victorian startups reach their economic potential, thanks to funding announced by the Andrews Labor Government today. The…

Bosch puts fully automated mask-production lines into operation

15 May 2020 In the fight against coronavirus, Bosch has now turned its hand to the fully automated production of face masks. Dr. Volkmar Denner, chairman of the board of management of Robert Bosch GmbH, today launched the…

Case Study: Accelerating drug discovery at the Melbourne Biomedical Precinct

14 May 2020 33% of Australia’s 2017-2018 drug discovery efforts occurred within the Melbourne Biomedical Precinct (the Precinct) and continues to grow. The Precinct consistently attracts 23% of National Health and Medical Research Council (NHMRC) funding annually, more…

Public information key to combatting rising ‘superbug’ threat

14 May 2020 With predictions that drug-resistant ‘superbugs’ could cause up to 10 million deaths a year by 2050, a new CSIRO survey has revealed a low level of community knowledge about antibiotics. The rise of superbugs, which…

Mucus breakthrough could help patients breathe easy

14 May 2020 A discovery about how mucus thickness is regulated could help to improve airway-clearing treatment options for people with chronic respiratory conditions such as asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD). New insights into…

Opyl Limited and AAMRI launch COVID-19 Social Media Guide to provide support to the Medical Research Institute sector

14 May 2020 Opyl Limited​ and the ​Association of Australian Medical Research Institutes​ (AAMRI) today launched a comprehensive Social Media Guide to support medical researchers in amplifying critical information through global digital communication channels, like social media, during…

MTPConnect – 2020 Sector Competitiveness Plan

14 May 2020 In November of 2015, MTPConnect was established as an independent, not-for-profit organisation to drive connectivity, innovation, productivity and competitiveness in Australia’s medical technology, biotechnology and pharmaceuticals sector.  In 2016, MTPConnect published a foundation plan for…

Home

News & opinion

Member Directory

Events